QUOTE AND NEWS
Wall Street Journal  Apr 2  Comment 
Takeda Pharmaceutical, the biggest drug company in Japan, has made a radical shift with the appointment of a foreigner, Christophe Weber, to a top post at the company.
Japan Today  Mar 31  Comment 
Takeda Pharmaceutical Co Ltd said on Monday it had received approval to manufacture and supply two vaccines for prevention of pandemic influenza from the Japanese health ministry. The New Drug Application for the vaccines, H5N1 "Takeda" and...
newratings.com  Mar 28  Comment 
HONG KONG (dpa-AFX) - Otsuka Pharmaceutical Co., Ltd. (OTSKF, OTSKY) has entered into an agreement with Takeda Pharmaceutical Co., Ltd. (TKPYY, TKPHF) for the future co-promotion of the sales of TAK-438 in Japan. TAK-438 was discovered by Takeda...
DailyFinance  Mar 27  Comment 
Furiex Pharmaceuticals, Inc. (NASDAQ: FURX) today confirmed that its partner Takeda Pharmaceuticals Company Limited (Takeda) will present sub-analyses from the global EXAMINE (EXamination of CArdiovascular OutcoMes: AlogliptIN...
FiercePharma  Mar 10  Comment 
The latest trial over Actos' bladder-cancer risks is set to begin. With thousands of other Actos cases pending against Takeda, the case already was destined to be closely watched. And now, one of the plaintiff's lawyers says he's planning to seek...
DailyFinance  Mar 7  Comment 
Furiex Pharmaceuticals, Inc. (NASDAQ: FURX) today confirmed that Takeda Pharmaceutical Company Limited announced that it has submitted a New Drug Application (NDA) to the Japanese Ministry of Health, Labour and Welfare for...
Financial Times  Mar 5  Comment 
Country’s biggest and oldest drugmaker wants more international investors after the recruitment of several senior foreign executives
FiercePharma  Mar 4  Comment 
Japan's health ministry is one of the world's toughest when it comes to demanding truth in advertising. The newest target of its scrutiny is Takeda Pharmaceutical, which is now admitting it may have mis-marketed its hypertension drug Blopress....
Wall Street Journal  Mar 3  Comment 
The CEO of Japan's largest pharmaceutical company admits to inappropriate expressions,' but denies any tampering with research data.




 
TOP CONTRIBUTORS

No more s***. All posts of this qaultiy from now on

Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki